Adma Biologics reported 12.28 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Adma Biologics 12.28 2.74 Jun/2026
Alnylam Pharmaceuticals 13.17 62.47 Sep/2026
BioCryst Pharmaceuticals 6.84 0.78 Jun/2026
Novavax 2.01 1.07 Dec/2025
Takeda 21.04 3.36 Sep/2026